Success and complication rate of total tubeless percutaneous nephrolitotomy

Success and complication rate of total tubeless percutaneous nephrolitotomy in comparing with standard percutaneous nephrolitotomy in patients with kidney stones

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201407256803N8

Enrollment

Registered

2014-08-05

Start date

2012-01-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal stone. Calculus of kidney

Interventions

Intervention 1: At the end of surgery, intervention group (totally tubeless PCNL group) was consisted of 40 patients without nephrostomy catheter, whose double J-stent was removed after the operation.

Treatment - Surgery

At the end of surgery, intervention group (totally tubeless PCNL group) was consisted of 40 patients without nephrostomy catheter, whose double J-stent was removed after the operation.

At the end of surgery, control group (Standard PCNL group) included 40 patients with ureteral catheter and nephrostomy catheter placement.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Informed written consent; Patients with stone-free status; No serious bleeding or collecting system perforation during the procedures; No clinical insignificant residual fragments (?4mm); No more than one access for surgery. Exclusion criteria: Patients with solitary kidney; Congenital renal anomalies; Bilateral PCNL; History of renal surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Operation duration. Timepoint: End of surgery. Method of measurement: Questionnaire.;Before and after operation hemoglobin level. Timepoint: Before and the day after surgery. Method of measurement: Questionnaire.;Before and after operation creatinine level. Timepoint: Before and the day after surgery. Method of measurement: Questionnaire.;Blood transfusion rate. Timepoint: End of surgery. Method of measurement: Questionnaire.;Complication rate after surgery. Timepoint: 1 day, 1 and 6 months after surgery. Method of measurement: Examine the patient and questionnaire.;Duration of hospitalization. Timepoint: At discharge. Method of measurement: Questionnaire.	—

Measure

Time frame

Operation duration. Timepoint: End of surgery. Method of measurement: Questionnaire.;Before and after operation hemoglobin level. Timepoint: Before and the day after surgery. Method of measurement: Questionnaire.;Before and after operation creatinine level. Timepoint: Before and the day after surgery. Method of measurement: Questionnaire.;Blood transfusion rate. Timepoint: End of surgery. Method of measurement: Questionnaire.;Complication rate after surgery. Timepoint: 1 day, 1 and 6 months after surgery. Method of measurement: Examine the patient and questionnaire.;Duration of hospitalization. Timepoint: At discharge. Method of measurement: Questionnaire.

—

Secondary

Measure	Time frame
Analgesic need. Timepoint: In the first 24 hours after surgery. Method of measurement: Questionnaire.;Type of analgesic. Timepoint: In the first 24 hours after surgery. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026